Trial Profile
Comparison of risk and patient-related benefit of treatment with etanercept in elderly patients with rheumatoid arthritis - CORELA
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms CORELA
- 24 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 25 Jun 2018 New trial record